FDA Adverse Event Malfunction Summary report: N

CAPIOX FX ADVANCE HOLLOW FIBER OXYGENATOR W INTEGRATED AF W HARDSHELL RES.

MDR report key: 24619216 · Received March 17, 2026

Report

Report Number
1124841-2026-00027
Event Type
Malfunction
Date Received
March 17, 2026
Date of Event
February 19, 2026
Report Date
May 29, 2026
Manufacturer
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
Product Code
DTZ
PMA / PMN Number
K151791
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EZ
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

TERUMO WILL NOT RECEIVE THE DEVICE FOR EVALUATION; HOWEVER, THE INVESTIGATION HAS YET TO BE COMPLETED. TERUMO PLANS ON SUBMITTING A FOLLOW-UP REPORT WHEN THE INVESTIGATION IS COMPLETE AND WHEN MORE INFORMATION BECOMES AVAILABLE. FOR THIS REASON, TERUMO REFERENCES EVALUATION CONCLUSION CODE 11. THE PRODUCT BEING REPORTED DOES NOT HAVE A PRIMARY UNIQUE DEVICE IDENTIFICATION (UDI) NUMBER ASSOCIATED AS IT IS NON-STERILE AND IS INTENDED FOR FURTHER PROCESSING INTO CONVENIENCE KITS. NON-STERILE PRODUCTS ARE SUBSEQUENTLY STERILIZED ONCE INCORPORATED INTO A CONVENIENCE KIT. NON-STERILE PRODUCT IS AT NO TIME INTRODUCED INTO COMMERCIAL DISTRIBUTION.

Description of Event or Problem · 0

THE USER FACILITY REPORTED TO TERUMO CARDIOVASCULAR THAT DURING CARDIOPULMONARY BYPASS, WITH A PLANNED BLOOD FLOW OF 6.5 LPM (DUE THE BMI) AND A GAS FLOW AT THE END OF EXTRACORPOREAL CIRCULATION (ECC) OF 10 LPM. TOWARDS THE END OF THE ECC (LENGTH 149 MIN) CONDENSATE ACCUMULATES IN THE OXYGENATOR CHAMBER, AND THE WATER LEVEL REACHES THE WHITE POROUS PART INSIDE. THE OXYGENATOR WAS FULL OF WATER UP TO THE SIDE OUTLET. A LARGE DROP OF WATER FILLED THE ENTIRE OUTFLOW / BLOCKED OUTFLOW. PRODUCT WAS NOT CHANGED OUT. PROCEDURE COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
143832 CAPIOX FX ADVANCE HOLLOW FIBER OXYGENATOR W INTEGRATED AF W HARDSHELL RES. OXYGENATOR, CARDIOPULMONARY BYPASS DTZ TERUMO CARDIOVASCULAR SYSTEMS CORPORATION 3ZZ*FX25RECA 4L23

Patients

Seq Age Sex Outcome Treatment
1